Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Recent developments in neoadjuvant therapy

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 17.05.12
Views: 13015

Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany

Prof Gunter Von Minckwitz talks to ecancer about assessing neoadjuvant therapy in breast cancer and recent developments at IMPAKT 2012 in Brussels, May 2012.


Recent developments have allowed patients to benefit by receiving better treatment through more accurate prognostics on the subtype of their tumour. There are now a series of trials that show an increase of complete pathological response in patients with HER2+ tumours.


Filming Supported by Amgen

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation